Related Experiment Video
Updated: Jul 19, 2026

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
Evidence of recurrent gene fusions in common epithelial tumors
Chandan Kumar-Sinha1, Scott A Tomlins, Arul M Chinnaiyan
1Advanced Centre for Treatment, Research and Education in Cancer, Kharghar, Navi Mumbai 410208, India.
Abstract:
Chromosomal aberrations that accompany carcinogenesis have been documented for almost half a century, with gene fusions being the most prevalent type of aberration. Gene fusions leading to generation of aberrant fusion proteins or aberrant expression of normal proteins are a potent route to carcinogenesis and have recently emerged as attractive therapeutic targets. Intriguingly, although gene fusions have been widely observed in hematological malignancies, they have been far less frequently described in the more-common epithelial carcinomas. It has been recently proposed that technical issues, rather than any fundamental dichotomy between hematological and solid cancers, account for the under-representation of gene fusions in epithelial cancers. Recent reports from our group support this contention and provide evidence of widespread recurrent gene fusions in prostate cancer using a novel analysis of gene-expression profiles. Here, we provide an appraisal of the state of the knowledge of gene fusions in epithelial cancers. Future implications of gene fusions in common epithelial cancers are also discussed.
Insights
Gene fusions, common in blood cancers, are now found in epithelial cancers due to improved detection. This discovery opens new therapeutic targets for common carcinomas.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Gene fusions are prevalent chromosomal aberrations in carcinogenesis, particularly in hematological malignancies.
- These gene fusions can lead to aberrant proteins or altered expression, driving cancer development and representing potential therapeutic targets.
- Historically, gene fusions were under-reported in epithelial carcinomas compared to hematological cancers, possibly due to technical limitations.
Purpose of the Study:
- To appraise the current knowledge regarding gene fusions in epithelial cancers.
- To discuss the implications of gene fusions in common epithelial cancers.
- To highlight recent findings supporting the widespread occurrence of gene fusions in epithelial cancers.
Main Methods:
- Analysis of gene-expression profiles using novel computational methods.
- Review and appraisal of existing literature on gene fusions in epithelial cancers.
- Case studies and evidence from recent research, including the authors' work on prostate cancer.
Main Results:
- Evidence suggests that gene fusions are widespread and recurrent in epithelial cancers, contrary to previous assumptions.
- Technical challenges in detection have likely contributed to the historical under-representation of gene fusions in solid tumors.
- Recurrent gene fusions have been identified in prostate cancer, supporting the revised understanding.
Conclusions:
- Gene fusions are a significant factor in epithelial carcinogenesis and are likely under-recognized due to detection challenges.
- The identification of recurrent gene fusions in epithelial cancers offers promising new avenues for targeted therapies.
- Future research should focus on comprehensive screening for gene fusions across various epithelial carcinomas to unlock their therapeutic potential.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Classification of Epithelial Tissues: Overview
Based on the number of cell layers,...

